MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
Titel:
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
Auteur:
Ascierto, Paolo A Schadendorf, Dirk Berking, Carola Agarwala, Sanjiv S van Herpen, Carla ML Queirolo, Paola Blank, Christian U Hauschild, Axel Beck, J Thaddeus St-Pierre, Annie Niazi, Faiz Wandel, Simon Peters, Malte Zubel, Angela Dummer, Reinhard